Diabetes monitoring support for African youth with type 1
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study helps children and young adults with type 1 diabetes in Uganda improve how their diabetes is tracked, likely by using an additional monitoring sensor. If you join, you’ll be asked to attend regular pediatric diabetes clinic visits and use the study monitoring device for part of the start period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be in Uganda and between ages 4 to 26 at the start of the study
- Have type 1 diabetes for at least 12 months
- Be using insulin therapy
- Have access to a cell phone
- Be able to attend the pediatric diabetes clinic about monthly
- Not already use a CGM (continuous glucose monitor) device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study tests using a continuous glucose monitor (CGM) in teenagers with type 1 diabetes in the Dominican Republic. The device tracks blood sugar levels around the clock to help manage their diabetes better. Participants will get support and education over about 15 months.
This study uses artificial intelligence to better understand how type 2 diabetes progresses in young people. By wearing a continuous glucose monitor, you may help researchers find patterns that could improve future care.
This trial tests a smart phone-based system that helps doctors monitor diabetes and adjust insulin treatment. It could make blood sugar control easier for people with type 2 diabetes.
This study tests a new extended-wear sensor that helps track glucose levels continuously. It is designed to see if a next-generation sensor is accurate and safe for people with diabetes.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.